DR
DrBioHacker
Community Contributor
Member since 2018
Views1.1kTotal number of views
Followers20Total number of followers
Comments0Total number of comments
No bio added yet
No link added
Undervalued Growth Stock with 6% Yield and Expansion Potential
1. Business Overview and Market Scope What the Business Does: Acrow is a Sydney-based provider of support services for the construction industry.Read more
1.1k
users have viewed this narrative1users have liked this narrative
1users have commented on this narrative
20users have followed this narrative
DR
AU$1.24
16.5% undervalued intrinsic discount
DrBioHacker's Fair Value
Revenue
9.81% p.a.
Profit Margin
13.13%
Future PE
13.26x
Price in 2030
AU$1.78